1982
DOI: 10.1111/j.1365-2141.1982.tb02819.x
|View full text |Cite
|
Sign up to set email alerts
|

The Wiskott‐Aldrich syndrome: studies on a possible defect in mitochondrial ATP resynthesis in platelets

Abstract: A possible defect in mitochondrial ATP resynthesis in platelets has been used for detection of Wiskott-Aldrich syndrome carriers (Shapiro et al, 1978). The detection was based on an abnormal adrenaline-induced platelet aggregation under conditions that only the mitochondria provide metabolic energy. We evaluated the test and found false negative and false positive results which raised doubts about the applicability of the test and the nature of the underlying defect. Direct analysis of mitochondrial ATP regene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1984
1984
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 13 publications
(10 reference statements)
0
3
0
Order By: Relevance
“…The discovery of a metabolic defect in WAS MDMs is, to our knowledge, the first description of its kind. However, the idea of a metabolic defect in WAS platelets was inferred as early as 40–50 years ago, with several studies observing a paucity of mitochondria and impaired mitochondrial energy production ( Trung et al, 1975 ; Verhoeven et al, 1989 ; Akkerman et al, 1982 ; Obydennyi et al, 2020 ). Although as yet unstudied, extending these metabolic defects to other immune cell lineages may go some way to explaining other immunophenotypic features of WAS including T cell anergy, progressive reduction in B and T lymphocytes with age and increasing development of autoinflammatory symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…The discovery of a metabolic defect in WAS MDMs is, to our knowledge, the first description of its kind. However, the idea of a metabolic defect in WAS platelets was inferred as early as 40–50 years ago, with several studies observing a paucity of mitochondria and impaired mitochondrial energy production ( Trung et al, 1975 ; Verhoeven et al, 1989 ; Akkerman et al, 1982 ; Obydennyi et al, 2020 ). Although as yet unstudied, extending these metabolic defects to other immune cell lineages may go some way to explaining other immunophenotypic features of WAS including T cell anergy, progressive reduction in B and T lymphocytes with age and increasing development of autoinflammatory symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…Stroke and stroke-like episodes are frequent complications in mitochondriopathy which is a rare disorder of the mitochondrial oxidative metabolism in diverse cell types (23). Human platelets contain mitochondria which play an important role for energy metabolism by the synthesis of ATP which is necessary for normal platelet responsiveness (24,25). To the best of our knowledge we conclude from the present investigation for the first time that exercise induces a decrease of intraplatelet ATP concentration in patients with mitochondriopathy and stroke.…”
Section: Discussionmentioning
confidence: 99%
“…The subjects studied were two patients with WAS, referred to as patients 1 and 2; 14 and 6 years old, respectively, who have been presented previously (patients Ill-a and Il-a, respectively* in ref. 7). Other subjects were the mothers of patients 1 and 2 (obligate carriers), a sister of patient 2 (possible carrier) and a patient with an isolated hexokinase type 1 deficiency, who has been described elsewhere (8,9).…”
Section: Patientsmentioning
confidence: 99%